DEFERIPRONE vs DELAFLOXACIN MEGLUMINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DEFERIPRONE vs DELAFLOXACIN MEGLUMINE: Safety Overview
| Metric | DEFERIPRONE | DELAFLOXACIN MEGLUMINE |
|---|---|---|
| Total FAERS Reports | 2,487 | 234 |
| Deaths Reported | 287 | 4 |
| Death Rate | 11.5% | 1.7% |
| Hospitalizations | 923 | 17 |
| Average Patient Age | 41.7 yrs | 61.6 yrs |
| % Female Patients | 57.4% | 47.4% |
| FDA Approval Date | Apr 20, 2018 | Jun 19, 2017 |
| Manufacturer | Chiesi USA, Inc. | Melinta Therapeutics, LLC |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |